Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Fluorodeoxyglucose F18 × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Oropharyngeal Neoplasms 2 Anus Neoplasms 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hodgkin Disease 1 HIV Infections 1 Ependymoma 1 Chordoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 7 fludarabine 6 fludarabine phosphate 3 Specimen Handling 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 zanubrutinib 2 polatuzumab vedotin 2 pirtobrutinib 2 obinutuzumab 2 glofitamab 2 Leukapheresis 2 Biopsy 2 tazemetostat 1 tafasitamab 1 pomalidomide 1 loncastuximab tesirine 1 ibrutinib 1 decitabine and cedazuridine drug combination 1 belinostat 1 axicabtagene ciloleucel 1 X-Rays 1 Vincristine 1 Prednisone 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Phantoms, Imaging 1 Nivolumab 1 MLN 8237 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡